share_log

HC Wainwright & Co. Reiterates Buy on Silence Therapeutics, Maintains $75 Price Target

Moomoo 24/7 ·  Mar 15 12:57

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment